60 likes | 66 Vues
Niraparib is a prescription medication used to treat adults who have advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. Continue reading to learn more about this drug.<br>Visit Us: https://synergydrugs.com/products/niraparib-in-india
E N D
Niraparib: Know more about this advanced ovarian cancer-treating drug Niraparib is a prescription medication used to treat adults who have advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. Continue reading to learn more about this drug.
Import Niraparib in India Niraparib is a cancer treatment that is given to women who have advanced ovarian cancer, which includes cancer of the ovaries, fallopian tubes (which connect the ovaries to the uterus), or the peritoneum (the lining around the abdomen). It can be used alone for maintenance (ongoing) treatment in women newly diagnosed with advanced cancer whose cancer has shrunk or disappeared after treatment with platinum-based medicines
Visit Us: https://synergydrugs.com/ How should this medicine be used? Niraparib is available as a capsule to be taken orally once daily. Niraparib should be taken at the same time every day, with or without food. If you get nausea after taking niraparib, take it once a day before bedtime. Follow your prescription label exactly, and ask your doctor or pharmacist to explain any parts you don't understand. Niraparib must be taken exactly as directed.
Import Niraparib in India Patients can easily Import Niraparib in India with the help of reliable global suppliers. Ovarian cancer is uncommon, and Zejula was designated as an "orphan medicine" (a medicine used in rare diseases) on August 4, 2010.
Visit Us: https://synergydrugs.com/ What benefits of Niraparib have been shown in studies? In two major studies involving over 1,000 women with ovarian cancer, including fallopian tube or peritoneal cancers, Zejula increased the time women lived without their disease worsening. Women with high-grade epithelial ovarian cancer who had previously been treated with two or more platinum-based therapies were included in one study. Before the last platinum-based therapy, the women had a long-term response (cancer had not progressed for at least 6 months).
Niraparib: Know more about this advanced ovarian cancer-treating drug Email Us: access@synergydrugs.com Call Us: +91 9677010046 Visit Us: https://synergydrugs.com/